Fresenius Medical Care Ag ADR (FMS)

$23.56 +0.06 (0.26%)
Market Cap 12.62B
Revenue (ttm) 22.21B
Net Income (ttm) 1.11B
EPS (ttm) N/A
PE Ratio 8.94
Forward PE 10.59
Profit Margin 4.98%
Debt to Equity Ratio 0.56
Volume 585,800
Avg Vol 668,934
Day's Range N/A - N/A
Shares Out 537.13M
Stochastic %K 6%
Beta 0.77
Analysts Hold
Price Target $23.98

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 49 6172 609 0
Address:
Else-Kröner-Strasse 1, Bad Homburg, Germany
Noname2022
Noname2022 Aug. 18 at 1:52 AM
$CRMD $DVA $FMS DaVita introduced ClearGuard HD in May 2019 as “standard of care for CVC patients.” Now CorMedix says upcoming data “will highlight the demonstrated efficacy of DefenCath when used in combination with chlorhexidine antimicrobial caps.” If durable Medicare Advantage reimbursement is secured in early 2027, does DefenCath eventually follow ClearGuard’s path at DaVita? https://stockanalysis.com/stocks/crmd/transcripts/669135-q2-2026/ https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083
1 · Reply
Yi_YandH
Yi_YandH Aug. 14 at 7:09 PM
$ICU Malaria is still bizarrely prevalent in the third world. The SCD-PED will be made available to its children at a greatly reduced cost. JMHO.. Perhaps both $FMS & $BAX will follow suit with their dialysis units. God Bless the Children. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(26)00146-4/fulltext
1 · Reply
Noname2022
Noname2022 Aug. 14 at 2:07 AM
DaVita’s $DVA Vafseo $AKBA rollout : • 100+ clinic pilot began 8/18/25 • Went “village-wide” on 11/10/25 • Pilot to village-wide access: 84 days Why this matters for $CRMD: • Similar timing could put DefenCath village-wide before potential MA contracts begin in early 2027 • That is a strong setup for $FMS -like adoption *Not a direct adoption comparison. Vafseo faced adherence issues, protocol changes, anemia-manager concerns, and decades of ESA inertia. Access did not equal immediate utilization.
4 · Reply
Noname2022
Noname2022 Aug. 13 at 12:23 PM
$AKBA $DVA $CRMD $FMS Amazing how the Davita CMO can impact patient care! (Forbes this week) https://www.forbes.com/councils/forbesbusinesscouncil/2026/08/12/leaving-the-bedside-doesnt-mean-leaving-patients-behind/
0 · Reply
Noname2022
Noname2022 Aug. 13 at 11:48 AM
$AKBA $DVA $CRMD $FMS Davita is amazing company that truly cares about savings patients from preventable CBRSI infections! *2nd leading cause of mortality in dialysis Pilot starts Q3 😁 https://www.globenewswire.com/news-release/2026/08/13/3344407/0/en/cormedix-therapeutics-reports-second-quarter-2026-financial-results-and-provides-business-update.html
3 · Reply
Bazziggr
Bazziggr Aug. 12 at 5:00 PM
$FMS DVA
0 · Reply
Yi_YandH
Yi_YandH Aug. 6 at 3:15 PM
$IOVA $ICU Medtronic supplies $FMS with SCD components for the device’s assembly. Don’t be surprised if they aren’t part of SeaStar’s international sales, training and distribution conglomerate soon to hatch. DYOR. NFA. https://www.medicaldevice-network.com/news/medtronic-ablation-system-lands-ventricular-arrhythmia-indication-expansion-in-europe/
0 · Reply
Gencooliveoil
Gencooliveoil Aug. 6 at 12:02 PM
$CRMD $AKBA $DVA $FMS
0 · Reply
Noname2022
Noname2022 Aug. 5 at 11:53 PM
$CRMD $FMS FMC Q2 earrings call “we are beginning to see the impact of our catheter-related bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection-related hospitalizations and also translates into lower patient mortality risk.” https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/Q2_2026_Earnings-call-transcript_Nasdaq.pdf
1 · Reply
REZZAYO
REZZAYO Aug. 5 at 7:04 PM
$CRMD $FMS $DVA Q2 Earnings Season Started to show the first signs of Defencath impact between the two LDOs Davita missed Treatment worsen versus it’s own Plan/ Internal Forecasts While Fresenius Reported favourable improvement on missed Treatment and mortality The Trend will likely expand exponentially
0 · Reply
Latest News on FMS
Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

2026-08-11T14:20:07.000Z - 7 days ago

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical price target raised to $25.80 from $25.50 at Bernstein

2026-08-06T12:06:06.000Z - 13 days ago

Fresenius Medical price target raised to $25.80 from $25.50 at Bernstein

Fresenius Medical price target lowered to EUR 32.30 from EUR 37.40 at JPMorgan

2026-08-05T19:15:38.000Z - 13 days ago

Fresenius Medical price target lowered to EUR 32.30 from EUR 37.40 at JPMorgan

Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley

2026-08-05T17:10:40.000Z - 13 days ago

Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley

Fresenius Medical price target lowered to $25 from $26 at Truist

2026-08-05T14:08:21.000Z - 14 days ago

Fresenius Medical price target lowered to $25 from $26 at Truist

Fresenius Medical Care AG Q2 Sales Increase

2026-08-05T05:36:00.000Z - 14 days ago

Fresenius Medical Care AG Q2 Sales Increase

Fresenius Medical Care AG (FMS) Shares Fall 5.0% -- What GF Score of 73 Tells Investors

2026-08-05T01:10:06.000Z - 14 days ago

Fresenius Medical Care AG (FMS) Shares Fall 5.0% -- What GF Score of 73 Tells Investors

EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

2026-08-04T12:43:23.000Z - 15 days ago

EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Tue, 04 Aug 2026 06:04:04 -0400 - 15 days ago

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Aug 4, 2026, 5:35 AM EDT - 15 days ago

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

FMS

Fresenius Medical Care AG Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 15 days ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2026

Fresenius Medical Care AG Earnings release: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 15 days ago

Fresenius Medical Care AG Earnings release: Q2 2026

Fresenius Medical Care AG Slides: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 15 days ago

Fresenius Medical Care AG Slides: Q2 2026

Fresenius Medical Care AG Quarterly report: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 15 days ago

Fresenius Medical Care AG Quarterly report: Q2 2026

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

Aug 4, 2026, 2:34 AM EDT - 15 days ago

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

FMS

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

Aug 3, 2026, 1:46 PM EDT - 15 days ago

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

FMS

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026

2026-08-03T17:01:04.000Z - 15 days ago

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026

Fresenius Medical Care AG (FMS) Shares Surge 3.4% -- What GF Score of 76 Tells Investors

2026-07-31T00:30:43.000Z - 19 days ago

Fresenius Medical Care AG (FMS) Shares Surge 3.4% -- What GF Score of 76 Tells Investors

Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas

2026-07-28T08:35:14.000Z - 22 days ago

Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas

Fresenius Medical Care Launches TherapyWise Analytics For Kidney Care Programs

2026-07-20T15:23:32.000Z - 4 weeks ago

Fresenius Medical Care Launches TherapyWise Analytics For Kidney Care Programs

Fresenius Medical price target raised to EUR 41 from EUR 40 at Citi

2026-07-17T17:30:18.000Z - 4 weeks ago

Fresenius Medical price target raised to EUR 41 from EUR 40 at Citi

Fresenius Medical initiated with a Market Perform at Bernstein

2026-07-16T08:45:26.000Z - 4 weeks ago

Fresenius Medical initiated with a Market Perform at Bernstein

Focus Graphite Announces SEDAR+ Filing of the NI 43-101 Technical Report with the Updated Mineral Resource for the Lac Tetepisca Project

Jun 22, 2026, 5:00 AM EDT - 2 months ago

Focus Graphite Announces SEDAR+ Filing of the NI 43-101 Technical Report with the Updated Mineral Resource for the Lac Tetepisca Project

FMS

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

Jun 15, 2026, 5:00 AM EDT - 2 months ago

Focus Graphite Completes Final Major ESIA Technical Study, Advancing Lac Knife Toward Permitting

FMS

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

FMS

Fresenius Medical launches first tranche of share buyback program

2026-05-28T11:56:15.000Z - 2 months ago

Fresenius Medical launches first tranche of share buyback program

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

May 28, 2026, 7:00 AM EDT - 2 months ago

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

FMS

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

May 27, 2026, 9:05 AM EDT - 3 months ago

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

FMS

Fresenius Medical announces EUR 1B share buyback program

2026-05-26T12:05:49.000Z - 3 months ago

Fresenius Medical announces EUR 1B share buyback program

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

May 26, 2026, 7:00 AM EDT - 3 months ago

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

FMS

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

May 21, 2026, 10:13 AM EDT - 3 months ago

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

FMS

Fresenius Medical Care AG Transcript: AGM 2026

May 21, 2026, 4:00 AM EDT - 3 months ago

Fresenius Medical Care AG Transcript: AGM 2026

Fresenius Medical reappoints CFO Martin Fischer

2026-05-20T17:05:10.000Z - 3 months ago

Fresenius Medical reappoints CFO Martin Fischer

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

May 20, 2026, 1:00 PM EDT - 3 months ago

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

FMS

Fresenius Medical Care AG Slides: Investor presentation

May 7, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Slides: Investor presentation

Fresenius Medical price target lowered to EUR 40 from EUR 42 at Deutsche Bank

2026-05-07T03:03:47.000Z - 3 months ago

Fresenius Medical price target lowered to EUR 40 from EUR 42 at Deutsche Bank

Fresenius Medical price target lowered to EUR 33 from EUR 34 at Morgan Stanley

2026-05-07T02:38:13.000Z - 3 months ago

Fresenius Medical price target lowered to EUR 33 from EUR 34 at Morgan Stanley

Fresenius Medical Care AG Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q1 2026

Fresenius Medical Care AG Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Slides: Q1 2026

Fresenius Medical Care AG Quarterly report: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Quarterly report: Q1 2026

Fresenius Medical reports Q1 EPS ex-items EUR0.91 vs. EUR0.84 last year

2026-05-05T11:50:11.000Z - 3 months ago

Fresenius Medical reports Q1 EPS ex-items EUR0.91 vs. EUR0.84 last year

Fresenius Medical sees FY26 revenue EUR19.628B

2026-05-05T11:49:09.000Z - 3 months ago

Fresenius Medical sees FY26 revenue EUR19.628B

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

May 5, 2026, 7:00 AM EDT - 3 months ago

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

FMS

Fresenius Medical Care Posts Lower Net Profit on One-Off Costs

May 5, 2026, 3:22 AM EDT - 3 months ago

Fresenius Medical Care Posts Lower Net Profit on One-Off Costs

FMS

Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll

May 5, 2026, 1:08 AM EDT - 3 months ago

Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll

FMS

Fresenius Medical price target raised to EUR 40 from EUR 39.50 at Citi

2026-04-24T16:35:55.000Z - 4 months ago

Fresenius Medical price target raised to EUR 40 from EUR 39.50 at Citi

Humacyte realigns ex-U.S. rights to Symvess through Fresenius Medical pact

2026-04-24T12:33:04.000Z - 4 months ago

Humacyte realigns ex-U.S. rights to Symvess through Fresenius Medical pact

HUMA

Fresenius Medical price target lowered to EUR 42 from EUR 44 at Deutsche Bank

2026-03-02T19:55:29.000Z - 6 months ago

Fresenius Medical price target lowered to EUR 42 from EUR 44 at Deutsche Bank

Fresenius Medical price target lowered to EUR 34 from EUR 36 at Morgan Stanley

2026-02-26T18:25:55.000Z - 6 months ago

Fresenius Medical price target lowered to EUR 34 from EUR 36 at Morgan Stanley

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Fresenius Medical Care AG Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Fresenius Medical Care AG Annual report: Q4 2025

Fresenius Medical Care AG Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Fresenius Medical Care AG Earnings release: Q4 2025

Fresenius Medical Care AG Slides: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Fresenius Medical Care AG Slides: Q4 2025

Fresenius Medical Care AG Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Fresenius Medical Care AG Annual report: Q4 2025

Fresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year

2026-02-24T12:11:35.000Z - 6 months ago

Fresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

Feb 24, 2026, 7:00 AM EST - 6 months ago

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

FMS

Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms

Feb 24, 2026, 6:42 AM EST - 6 months ago

Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms

FMS

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:00 AM EST - 6 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Fresenius Medical Care AG Earnings release: Q4 2025

Feb 24, 2026, 4:00 AM EST - 6 months ago

Fresenius Medical Care AG Earnings release: Q4 2025

Fresenius Medical Care AG Slides: Q4 2025

Feb 24, 2026, 4:00 AM EST - 6 months ago

Fresenius Medical Care AG Slides: Q4 2025

Fresenius Medical Care AG Slides: Investor presentation

Feb 24, 2026, 2:00 AM EST - 6 months ago

Fresenius Medical Care AG Slides: Investor presentation

Fresenius Medical Care's operating profit surges in Q4

Feb 24, 2026, 1:08 AM EST - 6 months ago

Fresenius Medical Care's operating profit surges in Q4

FMS

Fresenius Medical Care AG Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 7 months ago

Fresenius Medical Care AG Transcript: 44th Annual J.P. Morgan Healthcare Conference

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

Jan 9, 2026, 7:00 AM EST - 7 months ago

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

FMS

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

Dec 10, 2025, 8:00 AM EST - 9 months ago

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

FMS

Fresenius Medical Care AG Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q3 2025

Fresenius Medical Care AG Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Fresenius Medical Care AG Quarterly report: Q3 2025

Fresenius Medical Care AG Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Fresenius Medical Care AG Earnings release: Q3 2025

Fresenius Medical Care AG Slides: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Fresenius Medical Care AG Slides: Q3 2025

Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

Nov 4, 2025, 7:00 AM EST - 10 months ago

Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

FMS

Fresenius Medical Care beats quarterly profit estimates helped by cost cuts

Nov 4, 2025, 1:08 AM EST - 10 months ago

Fresenius Medical Care beats quarterly profit estimates helped by cost cuts

FMS

Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

Oct 30, 2025, 9:00 AM EDT - 10 months ago

Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

FMS

Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

Oct 1, 2025, 9:35 AM EDT - 11 months ago

Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

FMS

Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment

Sep 18, 2025, 3:30 PM EDT - 11 months ago

Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Aug 11, 2025, 7:00 AM EDT - 1 year ago

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Fresenius Medical Care AG Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2025

Fresenius Medical Care AG Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings release: Q2 2025

Fresenius Medical Care AG Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Quarterly report: Q2 2025

Fresenius Medical Care AG Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: Q2 2025

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

Aug 5, 2025, 7:00 AM EDT - 1 year ago

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical

Jul 18, 2025, 4:25 AM EDT - 1 year ago

$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Fresenius Medical Care AG Slides: Investor Presentation

Jun 20, 2025, 2:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: Investor Presentation

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Jun 17, 2025, 8:56 AM EDT - 1 year ago

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Jun 17, 2025, 7:00 AM EDT - 1 year ago

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Fresenius Medical Care AG Transcript: CMD 2025

Jun 17, 2025, 5:00 AM EDT - 1 year ago

Fresenius Medical Care AG Transcript: CMD 2025

Fresenius Medical Care AG Slides: FY 2025

Jun 17, 2025, 5:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: FY 2025

Fresenius Medical Care announces 1 bln euros share buyback programme

Jun 17, 2025, 4:08 AM EDT - 1 year ago

Fresenius Medical Care announces 1 bln euros share buyback programme

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

Jun 4, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

May 30, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

May 22, 2025, 11:45 AM EDT - 1 year ago

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

Fresenius Medical Care AG Transcript: AGM 2025

May 22, 2025, 4:00 AM EDT - 1 year ago

Fresenius Medical Care AG Transcript: AGM 2025

Fresenius Medical Care AG Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q1 2025

Fresenius Medical Care AG Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings release: Q1 2025

Fresenius Medical Care AG Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Quarterly report: Q1 2025

Fresenius Medical Care AG Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: Q1 2025

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

May 6, 2025, 7:00 AM EDT - 1 year ago

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

Fresenius Medical Care tops market expectations in 1st quarter

May 6, 2025, 1:04 AM EDT - 1 year ago

Fresenius Medical Care tops market expectations in 1st quarter

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Apr 9, 2025, 6:32 PM EDT - 1 year ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Mar 13, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Fresenius Medical Care's stock falls on Fresenius' stake sale

Mar 4, 2025, 3:57 AM EST - 1 year ago

Fresenius Medical Care's stock falls on Fresenius' stake sale

Fresenius Medical Care AG Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2024

Fresenius Medical Care AG Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Annual report: Q4 2024

Fresenius Medical Care AG Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Annual report: Q4 2024

Fresenius Medical Care AG Quarterly report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Quarterly report: Q4 2024

Fresenius Medical Care AG Slides: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Slides: Q4 2024

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Feb 25, 2025, 7:00 AM EST - 1 year ago

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Fresenius Medical Care slightly beats market estimates in fourth quarter

Feb 25, 2025, 1:14 AM EST - 1 year ago

Fresenius Medical Care slightly beats market estimates in fourth quarter

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Feb 24, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

DGX

Fresenius Medical Care AG Transcript: 43rd Annual J.P. Morgan Healthcare Conference

Jan 14, 2025, 1:30 PM EST - 1 year ago

Fresenius Medical Care AG Transcript: 43rd Annual J.P. Morgan Healthcare Conference

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Dec 23, 2024, 9:00 AM EST - 1 year ago

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Fresenius Medical Care returns to Dax 40 Index

Dec 20, 2024, 11:23 AM EST - 1 year ago

Fresenius Medical Care returns to Dax 40 Index

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Nov 5, 2024, 8:33 PM EST - 1 year ago

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Fresenius Medical Care AG Earnings Call Transcript: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q3 2024

Fresenius Medical Care AG Earnings release: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Earnings release: Q3 2024

Fresenius Medical Care AG Quarterly report: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Quarterly report: Q3 2024

Fresenius Medical Care AG Slides: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Slides: Q3 2024

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Nov 5, 2024, 7:00 AM EST - 1 year ago

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Oct 21, 2024, 11:04 AM EDT - 1 year ago

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Fresenius Medical Care AG Transcript: Expert Call

Sep 16, 2024, 9:00 AM EDT - 2 years ago

Fresenius Medical Care AG Transcript: Expert Call

Fresenius Medical Care AG Slides: Expert Call

Sep 16, 2024, 9:00 AM EDT - 2 years ago

Fresenius Medical Care AG Slides: Expert Call

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Jul 30, 2024, 9:30 PM EDT - 2 years ago

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Fresenius Medical Care AG Earnings Call Transcript: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2024

Fresenius Medical Care AG Quarterly report: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Quarterly report: Q2 2024

Fresenius Medical Care AG Earnings release: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Earnings release: Q2 2024

Fresenius Medical Care AG Slides: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Slides: Q2 2024

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Jul 30, 2024, 7:00 AM EDT - 2 years ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Noname2022
Noname2022 Aug. 18 at 1:52 AM
$CRMD $DVA $FMS DaVita introduced ClearGuard HD in May 2019 as “standard of care for CVC patients.” Now CorMedix says upcoming data “will highlight the demonstrated efficacy of DefenCath when used in combination with chlorhexidine antimicrobial caps.” If durable Medicare Advantage reimbursement is secured in early 2027, does DefenCath eventually follow ClearGuard’s path at DaVita? https://stockanalysis.com/stocks/crmd/transcripts/669135-q2-2026/ https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083
1 · Reply
Yi_YandH
Yi_YandH Aug. 14 at 7:09 PM
$ICU Malaria is still bizarrely prevalent in the third world. The SCD-PED will be made available to its children at a greatly reduced cost. JMHO.. Perhaps both $FMS & $BAX will follow suit with their dialysis units. God Bless the Children. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(26)00146-4/fulltext
1 · Reply
Noname2022
Noname2022 Aug. 14 at 2:07 AM
DaVita’s $DVA Vafseo $AKBA rollout : • 100+ clinic pilot began 8/18/25 • Went “village-wide” on 11/10/25 • Pilot to village-wide access: 84 days Why this matters for $CRMD: • Similar timing could put DefenCath village-wide before potential MA contracts begin in early 2027 • That is a strong setup for $FMS -like adoption *Not a direct adoption comparison. Vafseo faced adherence issues, protocol changes, anemia-manager concerns, and decades of ESA inertia. Access did not equal immediate utilization.
4 · Reply
Noname2022
Noname2022 Aug. 13 at 12:23 PM
$AKBA $DVA $CRMD $FMS Amazing how the Davita CMO can impact patient care! (Forbes this week) https://www.forbes.com/councils/forbesbusinesscouncil/2026/08/12/leaving-the-bedside-doesnt-mean-leaving-patients-behind/
0 · Reply
Noname2022
Noname2022 Aug. 13 at 11:48 AM
$AKBA $DVA $CRMD $FMS Davita is amazing company that truly cares about savings patients from preventable CBRSI infections! *2nd leading cause of mortality in dialysis Pilot starts Q3 😁 https://www.globenewswire.com/news-release/2026/08/13/3344407/0/en/cormedix-therapeutics-reports-second-quarter-2026-financial-results-and-provides-business-update.html
3 · Reply
Bazziggr
Bazziggr Aug. 12 at 5:00 PM
$FMS DVA
0 · Reply
Yi_YandH
Yi_YandH Aug. 6 at 3:15 PM
$IOVA $ICU Medtronic supplies $FMS with SCD components for the device’s assembly. Don’t be surprised if they aren’t part of SeaStar’s international sales, training and distribution conglomerate soon to hatch. DYOR. NFA. https://www.medicaldevice-network.com/news/medtronic-ablation-system-lands-ventricular-arrhythmia-indication-expansion-in-europe/
0 · Reply
Gencooliveoil
Gencooliveoil Aug. 6 at 12:02 PM
$CRMD $AKBA $DVA $FMS
0 · Reply
Noname2022
Noname2022 Aug. 5 at 11:53 PM
$CRMD $FMS FMC Q2 earrings call “we are beginning to see the impact of our catheter-related bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection-related hospitalizations and also translates into lower patient mortality risk.” https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/Q2_2026_Earnings-call-transcript_Nasdaq.pdf
1 · Reply
REZZAYO
REZZAYO Aug. 5 at 7:04 PM
$CRMD $FMS $DVA Q2 Earnings Season Started to show the first signs of Defencath impact between the two LDOs Davita missed Treatment worsen versus it’s own Plan/ Internal Forecasts While Fresenius Reported favourable improvement on missed Treatment and mortality The Trend will likely expand exponentially
0 · Reply
Noname2022
Noname2022 Aug. 5 at 4:01 PM
$CRMD $AKBA $DVA $FMS
2 · Reply
Estimize
Estimize Aug. 5 at 10:01 AM
Wall St is expecting 0.62 EPS for $FMS Q3 [Reporting 11/03 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
Noname2022
Noname2022 Aug. 4 at 11:57 AM
$CRMD $FMS “As already indicated, we are beginning to see the impact of our catheter-related- bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection- related hospitalizations and also translates into lower patient mortality risk” https://stockanalysis.com/quote/etr/FME/transcripts/552777-q2-2026/
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 9:31 AM
https://www.marketbeat.com/earnings/reports/2026-8-3-fresenius-medical-care-ag-co-kgaa-stock/ $FMS Fresenius Medical Care AG & Co. KGaA Ea
0 · Reply
Noname2022
Noname2022 Aug. 4 at 2:57 AM
$CRMD $FMS Just posting for awarness - New CEO of care delivery for Fresenius who started 8.1.26. https://freseniusmedicalcare.com/en/media/newsroom/fresenius-medical-care-appoints-cassie-mclean-as-new-management-board-member-for-care-delivery/?utm_source=linkedin&utm_medium=organic_social&utm_campaign=03_august2026_caredelivery_announcement&utm_content=corporate
0 · Reply
Noname2022
Noname2022 Aug. 3 at 9:09 PM
$CRMD $DVA $FMS $AKBA https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/FME_Q2_2026_Analyst_Presentation.pdf
1 · Reply
Noname2022
Noname2022 Aug. 3 at 8:28 PM
$CRMD $AKBA $FMS $DVA
0 · Reply
Noname2022
Noname2022 Aug. 3 at 6:31 PM
$CRMD $FMS Fresenius Q2 math: Implied incremental TDAPA benefit: €42.7M ≈ $49.7M at $1.163/€ Q2 reimbursement: $4.741/unit × 30 units/vial = $142.23/vial 2 vials/session × 3 sessions/week × 13 weeks = 78 vials/patient 78 × $142.23 = $11,094 reimbursement/patient $49.7M ÷ $11,094 = ~4,480 patients minimum
1 · Reply
Noname2022
Noname2022 Aug. 3 at 6:09 PM
$CRMD $FMS Fresenius Q2 financials imply approximately €42.7M of incremental TDAPA benefit above the phosphate-binder contribution already included in Q2 2025. With phosphate binders likely flat to slightly down YoY, that points to roughly €45M from DefenCath in Q2—right in line with expectations. https://freseniusmedicalcare.com/en/media/newsroom/q2-2026/?utm_source=linkedin&utm_medium=organic_social&utm_campaign=03_august2026_q2_financieal_earnings&utm_content=helen https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/FME_Q2_2026_Financial_Tables.pdf
0 · Reply
Noname2022
Noname2022 Aug. 2 at 1:06 PM
$CRMD $ICUI $DVA $FMS Clearguard HD: guessing DVA contract & best guess at access trends based on their marketing data (Fresenius uses both Clearguard HD & Defencath!) On the Q2 2024 call, ICU Medical said it had: “recently signed a multi-year committed agreement with a leading U.S. operator of dialysis clinics” Management said the agreement would expand its evidence base and help attract other dialysis operators. https://stockanalysis.com/stocks/icui/transcripts/192237-q2-2024/
0 · Reply
Yi_YandH
Yi_YandH Aug. 1 at 7:17 PM
$ICU Vantive’s Cadillac dialysis machine. The Quelimmune SCD-PED will be connected to it(or $FMS ‘s Lincoln, a similar machine) for AKI/Sepsis treatment in 40-50 Children’s hospitals in 4-6 months. The SCD-Adult, will see its connection to the pictured dialysis machine(or a Fresenius built machine)in 50-250 Major US hospitals for the treatment of AKI, Sepsis and ARDS in 6-12 months. Book it. Add. Invest. DYOR. NFA.
0 · Reply
Gencooliveoil
Gencooliveoil Jul. 31 at 1:24 PM
$CRMD $FMS
0 · Reply